Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway

• Main Authors: Hongbo Li (Author), Zhenkai Wang (Author), Jie Zhang (Author), Youlei Wang (Author), Chen Yu (Author), Jinjin Zhang (Author), Xiaodong Song (Author), Changjun Lv (Author)
• Format: Book
• Published: BMC, 2018-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Feifukang (FFK) is a traditional Chinese medicine composed of herbs that protect lung function. However, difficulty arises regarding the clinical application of FFK due to the complex mechanism of Chinese medicines. This study aimed to investigate the efficacy of FFK and explore...